CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin.

about

CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin.

Item

http://www.wikidata.org/entity/Q35933626

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

CYP3A5 genotyping for assessin ...... simvastatin and atorvastatin.

@ast

CYP3A5 genotyping for assessin ...... simvastatin and atorvastatin.

@en

type

Item

label

CYP3A5 genotyping for assessin ...... simvastatin and atorvastatin.

@ast

CYP3A5 genotyping for assessin ...... simvastatin and atorvastatin.

@en

prefLabel

CYP3A5 genotyping for assessin ...... simvastatin and atorvastatin.

@ast

CYP3A5 genotyping for assessin ...... simvastatin and atorvastatin.

@en

P1476

CYP3A5 genotyping for assessin ...... simvastatin and atorvastatin.

@en

P2093

Constantinos Mihas

http://www.w3.org/2001/XMLSchema#string

Genovefa Kolovou

http://www.w3.org/2001/XMLSchema#string

Georgia Ragia

http://www.w3.org/2001/XMLSchema#string

Ioannis Vasiliadis

http://www.w3.org/2001/XMLSchema#string

Olga Diakoumakou

http://www.w3.org/2001/XMLSchema#string

Sophie Mavrogeni

http://www.w3.org/2001/XMLSchema#string

Vana Kolovou

http://www.w3.org/2001/XMLSchema#string

Vangelis G Manolopoulos

http://www.w3.org/2001/XMLSchema#string

Vassiliki Vartela

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association of lipid-lowering response to statins in combined study populations

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.

Simvastatin: two decades in a circle.

Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin.

Frequency of CYP450 enzyme gene polymorphisms in the Greek population: review of the literature, original findings and clinical significance.

Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.

P304

129-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S1415-4757382220140239

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279270847

http://www.w3.org/2001/XMLSchema#string

P698

26273214

http://www.w3.org/2001/XMLSchema#string

P932

4530653

http://www.w3.org/2001/XMLSchema#string